CHRU Montpellier, Inserm U1061, Montpellier, Université Montpellier, France.
Eur Neuropsychopharmacol. 2012;22 Suppl 3:S476-81. doi: 10.1016/j.euroneuro.2012.07.009.
The cyclic nature of depressive illness, disturbance of diurnal mood variations, and disturbed sleep-wake and physiological rhythms all suggest that dysfunction of the circadian time-keeping system may underlie the pathophysiology of depression. Circadian misalignment of the phase-delayed type appears to be the most common shift in unipolar disorder patients and misalignment between the timing of sleep and the pacemaker is correlated with depressive symptom severity. Profiles of diurnal mood variation are associated with risks of depression severity and may predict response to treatments. As circadian disturbances are at the core of depression, normalizing circadian rhythm may be a fruitful avenue for new therapeutic targets in depression. The innovative antidepressant agomelatine possesses resynchronizing properties that may be related to its original profile and offers an opportunity to achieve our goals in treating depressed people.
抑郁障碍具有周期性、日间情绪变化紊乱以及睡眠-觉醒和生理节律紊乱等特征,这提示昼夜节律计时系统功能障碍可能是抑郁障碍的病理生理学基础。单相障碍患者最常见的昼夜节律失调类型为相位延迟型,睡眠和生物钟时间之间的失协调与抑郁症状严重程度相关。日间情绪变化特征与抑郁严重程度的风险相关,并且可能预测对治疗的反应。由于昼夜节律紊乱是抑郁的核心,因此使昼夜节律正常化可能是抑郁治疗新靶点的一个有希望的途径。创新性抗抑郁药阿戈美拉汀具有再同步作用,这可能与其原有的特征有关,并为我们实现治疗抑郁人群的目标提供了机会。